Proteinase inhibitors: the result of rational drug design
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Carlisle, Mass.
Pharmacotherapy Publ.
1994
|
| Series: | Pharmacotherapy
14,6,2 |
| Subjects: | |
| Item Description: | Einzelaufnahme eines Zs.-Heftes |
| Physical Description: | 32 S. Ill., graph. Darst. |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010812145 | ||
| 003 | DE-604 | ||
| 005 | 19960625 | ||
| 007 | t | ||
| 008 | 960625s1994 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)32775053 | ||
| 035 | |a (DE-599)BVBBV010812145 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Proteinase inhibitors |b the result of rational drug design |c guest ed.: Rebecca Coleman |
| 264 | 1 | |a Carlisle, Mass. |b Pharmacotherapy Publ. |c 1994 | |
| 300 | |a 32 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Pharmacotherapy |v 14,6,2 | |
| 500 | |a Einzelaufnahme eines Zs.-Heftes | ||
| 650 | 4 | |a Drug Design |v Congresses | |
| 650 | 4 | |a HIV Infections |x drug therapy |v Congresses | |
| 650 | 4 | |a HIV Protease Inhibitors |x chemistry |v Congresses | |
| 650 | 4 | |a HIV Protease Inhibitors |x pharmacology |v Congresses | |
| 650 | 4 | |a HIV Protease Inhibitors |x therapeutic use |v Congresses | |
| 650 | 4 | |a HIV |x drug effects |v Congresses | |
| 650 | 0 | 7 | |a Proteaseinhibitor |0 (DE-588)4130450-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Proteaseinhibitor |0 (DE-588)4130450-0 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Coleman, Rebecca |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007224025 | ||
Record in the Search Index
| _version_ | 1804125297411358720 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV010812145 |
| ctrlnum | (OCoLC)32775053 (DE-599)BVBBV010812145 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01540nam a2200421 cb4500</leader><controlfield tag="001">BV010812145</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19960625 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">960625s1994 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)32775053</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010812145</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Proteinase inhibitors</subfield><subfield code="b">the result of rational drug design</subfield><subfield code="c">guest ed.: Rebecca Coleman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Carlisle, Mass.</subfield><subfield code="b">Pharmacotherapy Publ.</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">32 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacotherapy</subfield><subfield code="v">14,6,2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zs.-Heftes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV Infections</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV Protease Inhibitors</subfield><subfield code="x">chemistry</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV Protease Inhibitors</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV Protease Inhibitors</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV</subfield><subfield code="x">drug effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteaseinhibitor</subfield><subfield code="0">(DE-588)4130450-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Proteaseinhibitor</subfield><subfield code="0">(DE-588)4130450-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Coleman, Rebecca</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007224025</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Aufsatzsammlung Konferenzschrift |
| id | DE-604.BV010812145 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:59:19Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007224025 |
| oclc_num | 32775053 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 32 S. Ill., graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Pharmacotherapy Publ. |
| record_format | marc |
| series2 | Pharmacotherapy |
| spelling | Proteinase inhibitors the result of rational drug design guest ed.: Rebecca Coleman Carlisle, Mass. Pharmacotherapy Publ. 1994 32 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Pharmacotherapy 14,6,2 Einzelaufnahme eines Zs.-Heftes Drug Design Congresses HIV Infections drug therapy Congresses HIV Protease Inhibitors chemistry Congresses HIV Protease Inhibitors pharmacology Congresses HIV Protease Inhibitors therapeutic use Congresses HIV drug effects Congresses Proteaseinhibitor (DE-588)4130450-0 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Proteaseinhibitor (DE-588)4130450-0 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Coleman, Rebecca Sonstige oth |
| spellingShingle | Proteinase inhibitors the result of rational drug design Drug Design Congresses HIV Infections drug therapy Congresses HIV Protease Inhibitors chemistry Congresses HIV Protease Inhibitors pharmacology Congresses HIV Protease Inhibitors therapeutic use Congresses HIV drug effects Congresses Proteaseinhibitor (DE-588)4130450-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| subject_GND | (DE-588)4130450-0 (DE-588)4076066-2 (DE-588)4143413-4 (DE-588)1071861417 |
| title | Proteinase inhibitors the result of rational drug design |
| title_auth | Proteinase inhibitors the result of rational drug design |
| title_exact_search | Proteinase inhibitors the result of rational drug design |
| title_full | Proteinase inhibitors the result of rational drug design guest ed.: Rebecca Coleman |
| title_fullStr | Proteinase inhibitors the result of rational drug design guest ed.: Rebecca Coleman |
| title_full_unstemmed | Proteinase inhibitors the result of rational drug design guest ed.: Rebecca Coleman |
| title_short | Proteinase inhibitors |
| title_sort | proteinase inhibitors the result of rational drug design |
| title_sub | the result of rational drug design |
| topic | Drug Design Congresses HIV Infections drug therapy Congresses HIV Protease Inhibitors chemistry Congresses HIV Protease Inhibitors pharmacology Congresses HIV Protease Inhibitors therapeutic use Congresses HIV drug effects Congresses Proteaseinhibitor (DE-588)4130450-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| topic_facet | Drug Design Congresses HIV Infections drug therapy Congresses HIV Protease Inhibitors chemistry Congresses HIV Protease Inhibitors pharmacology Congresses HIV Protease Inhibitors therapeutic use Congresses HIV drug effects Congresses Proteaseinhibitor Pharmakotherapie Aufsatzsammlung Konferenzschrift |
| work_keys_str_mv | AT colemanrebecca proteinaseinhibitorstheresultofrationaldrugdesign |